Dr. Lisa M. Barroilhet, MD

Dr. Barroilhet practices at University Health Services - Madison (Highland Ave) in Madison, Wisconsin.

Dr. Barroilhet's NPI, 1730300443, was assigned on May 1, 2007. Dr. Barroilhet graduated from University of Minnesota Medical School in 2005. Dr. Barroilhet holds Wisconsin license 57619.

Dr. Barroilhet's primary practice is University Health Services - Madison (Highland Ave), at 600 Highland Ave, Madison, WI 53792. The practice phone is (608) 265-1978.

Dr. Barroilhet's primary practice is University Health Services - Madison (Highland Ave) in Madison, Wisconsin. Dr. Barroilhet is also affiliated with University Hospital. The medical group on file is UW Health. Dmand AI also links Dr. Barroilhet to 1 more hospital and 3 medical groups, each named with a free account. Dr. Barroilhet's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barroilhet practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Barroilhet's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Barroilhet is licensed in Wisconsin.

CMS data shows 134 Medicare services from Dr. Barroilhet across 4 procedure codes in 2024, for 100 Medicare patients. Medicare paid $8,390 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 100 Medicare patients who saw Dr. Barroilhet in 2024. The largest group is 65 to 74, with 55 patients. 70% of them have high blood pressure, and 60% have cancer. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barroilhet's median patient age at 62, with 97% women.

In 2024, Dr. Barroilhet wrote 95 Medicare Part D claims for 31 patients. 72% of them were for generic drugs. CMS names the drug for 47 of them, across 3 drugs with 11 or more claims each, at $234,814 in total drug cost. In 2023, CMS named 56 claims across 3 drugs.

Dr. Barroilhet accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Barroilhet as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 55 papers to Dr. Barroilhet, published from 2011 to 2025. 2022 was the busiest year, with 8. The most frequent topics are Ovarian Neoplasms, Ultrasonography and Adnexal Diseases. Dr. Barroilhet has published most often in Gynecol Oncol. Dr. Barroilhet's most frequent co-authors are Elizabeth A. Sadowski, MD, Krupa K. Patel-Lippmann, MD and Jessica Bess Robbins, MD.

Dmand AI links Dr. Barroilhet to 10 clinical trials, 4 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Fallopian Tube Diseases, Fallopian Tube Neoplasms and Carcinosarcoma. National Cancer Institute (NCI) sponsors the most, 7.

CMS Open Payments shows 5 general payments to Dr. Barroilhet from 3 drug and device companies from 2020 to 2024. Consulting fees make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,998.

Dr. Barroilhet graduated from University of Minnesota Medical School in 2005.